PIC1 Injection Therapy for Relapsed/Refractory B-NHL

Clinical trial NCT07456371 · RECRUITING

Trial details

NCT number: NCT07456371
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2026-03-01
Primary completion: 2026-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.